AI Article Synopsis

  • The placenta has a layer called syncytiotrophoblast (SCT) that acts as a barrier between the mother and baby, and problems with it can lead to issues like preeclampsia.
  • A gene called P57 is important for the cells in the placenta to change and combine into SCT, and if it's not working right, it can cause health problems for both mom and baby.
  • Researchers discovered that a protein named STK40 interacts with P57 and can affect the fusion of placenta cells—too much STK40 might lead to conditions like preeclampsia.

Article Abstract

Background: The syncytiotrophoblast (SCT) layer in the placenta serves as a crucial physical barrier separating maternal-fetal circulation, facilitating essential signal and substance exchange between the mother and fetus. Any abnormalities in its formation or function can result in various maternal syndromes, such as preeclampsia. The transition of proliferative villous cytotrophoblasts (VCT) from the mitotic cell cycle to the G0 phase is a prerequisite for VCT differentiation and their fusion into SCT. The imprinting gene P57, specifically expressed in intermediate VCT capable of fusion, plays a pivotal role in driving this key event. Moreover, aberrant expression of P57 has been linked to pathological placental conditions and adverse fetal outcomes.

Methods: Validation of STK40 interaction with P57 using rigid molecular simulation docking and co-immunoprecipitation. STK40 expression was modulated by lentivirus in BeWo cells, and the effect of STK40 on trophoblast fusion was assessed by real-time quantitative PCR, western blot, immunofluorescence, and cell viability and proliferation assays. Co-immunoprecipitation, transcriptome sequencing, and western blot were used to determine the potential mechanisms by which STK40 regulates P57.

Results: In this study, STK40 has been identified as a novel interacting protein with P57, and its expression is down-regulated during the fusion process of trophoblast cells. Overexpressing STK40 inhibited cell fusion in BeWo cells while stimulating mitotic cell cycle activity. Further experiments indicated that this effect is attributed to its specific binding to the CDK-binding and the Cyclin-binding domains of P57, mediating the E3 ubiquitin ligase COP1-mediated ubiquitination and degradation of P57. Moreover, abnormally high expression of STK40 might significantly contribute to the occurrence of preeclampsia.

Conclusions: This study offers new insights into the role of STK40 in regulating the protein-level homeostasis of P57 during placental development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11414097PMC
http://dx.doi.org/10.1186/s12967-024-05360-yDOI Listing

Publication Analysis

Top Keywords

stk40
9
trophoblast fusion
8
p57
8
mitotic cell
8
cell cycle
8
bewo cells
8
western blot
8
fusion
6
stk40 inhibits
4
inhibits trophoblast
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!